The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myeloma

This study aimed to investigate the activity of arsenic trioxide (As(2)O(3)) combined with ascorbic acid, ifosfamide, and prednisone chemotherapy in patients with repeatedly relapsed and refractory multiple myeloma (MM). Here, we retrospectively analyzed medical data of 30 MM patients showing progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Sun, Wan-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399549/
https://www.ncbi.nlm.nih.gov/pubmed/25914547
http://dx.doi.org/10.2147/OTT.S81022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399549/
https://www.ncbi.nlm.nih.gov/pubmed/25914547
http://dx.doi.org/10.2147/OTT.S81022

Ejemplares similares